What happened
U. Today published a piece Friday morning headlined "XRP to $2? Analyzing How Nasdaq Listing Could Impact Token Price," built around Evernorth's pending Nasdaq debut and its relationship with XRP.
The outlet treats the listing as the near-term event the market is pricing, and the $2 figure as the level traders are using to frame the move. Timing matters. The piece hit the wire at 04:00 UTC on October 3, ahead of the US cash open, which is when thin order books do most of their damage in either direction.
Evernorth itself has been positioned publicly as an XRP-exposed vehicle, which is why a routine Nasdaq listing is being read as a token-level catalyst rather than a straight equity story. The specifics - final ticker, free float, lockup terms, and the exact listing date - sit with the issuer and are the pieces to pin down from the filing rather than the analysis column.
Why it matters
The reflexivity is the whole trade. When an equity whose balance sheet or operating model is tied to a crypto asset lists on a major US exchange, the token gets a new, regulated demand channel: pensions, RIAs, and funds that can't touch spot can own the stock. MicroStrategy drew the template for bitcoin.
The XRP equity thesis has lagged, in part because of years of litigation overhang around the token's US status. A Nasdaq listing with explicit XRP exposure in the prospectus changes the shape of that overhang in practice, even if nothing changes legally overnight. The $2 figure in U.